Peter Calabresi

Q: What Schools Are Affiliated With Peter Calabresi

Peter Calabresi is affiliated with the following schools: University of South Florida, Johns Hopkins University

Peter Calabresi's AcademicInfluence.com Rankings

Peter Calabresi

Medical

#668

World Rank

#891

Historical Rank

#245

USA Rank

Neurology

#133

World Rank

#199

Historical Rank

#39

USA Rank

medical Degrees

Download Badge

Medical

Why Is Peter Calabresi Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Peter Arthur Calabresi is an American neuroscientist and neurologist who studies multiple sclerosis. He is Professor of Neurology, Neuroscience, and Ophthalmology at the Johns Hopkins School of Medicine, where he directs the Division of Neuroimmunology and Johns Hopkins Multiple Sclerosis Center.

(See a Problem?)

Peter Calabresi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Defining the clinical course of multiple sclerosis (2014) (2372)
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. (2010) (2329)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. (2006) (1274)
Tract probability maps in stereotaxic spaces: Analyses of white matter anatomy and tract-specific quantification (2008) (1245)
Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial (2009) (784)
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. (2006) (649)
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial (2014) (647)
Multiple Sclerosis (2018) (641)
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial (2011) (625)
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility (2019) (589)
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis (2010) (502)
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial (2000) (499)
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases (2006) (494)
Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA (1997) (478)
Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial (2008) (476)
Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS? (2010) (438)
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. (2003) (409)
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity (2018) (391)
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials (2009) (373)
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis (2010) (332)
A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions (2010) (330)
Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. (2012) (313)
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis (2017) (310)
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis (2017) (310)
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study (2014) (306)
The APOSTEL recommendations for reporting quantitative optical coherence tomography studies (2016) (303)
Optical coherence tomography: a window into the mechanisms of multiple sclerosis (2008) (302)
Optical coherence tomography and disease subtype in multiple sclerosis (2007) (295)
Anti-&agr;4 integrin therapy for multiple sclerosis: Mechanisms and rationale (2005) (292)
Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. (2011) (284)
Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four‐year study (2015) (272)
Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies (2009) (271)
Retinal layer segmentation of macular OCT images using boundary classification (2013) (266)
Statistical normalization techniques for magnetic resonance imaging (2014) (262)
The incidence and significance of anti-natalizumab antibodies (2007) (260)
Ganglion cell loss in relation to visual disability in multiple sclerosis. (2012) (257)
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study (2012) (256)
Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness (2011) (248)
Diagnosis and management of multiple sclerosis. (2004) (243)
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria (2015) (234)
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study (2016) (231)
Targeting Effector Memory T Cells with a Selective Peptide Inhibitor of Kv1.3 Channels for Therapy of Autoimmune Diseases (2005) (230)
Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein (2013) (212)
Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis (2015) (210)
High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord. (2007) (207)
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning (2013) (197)
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. (2012) (196)
Health‐related quality of life in multiple sclerosis: effects of natalizumab (2007) (190)
The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. (2005) (185)
Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. (2009) (185)
Diffusion Tensor Magnetic Resonance Imaging of Wallerian Degeneration in Rat Spinal Cord after Dorsal Root Axotomy (2009) (182)
Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients (2006) (181)
Increases in soluble VCAM‐1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon β‐1b (1997) (174)
Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination (2019) (171)
MRI of the corpus callosum in multiple sclerosis: association with disability (2010) (167)
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis. (2013) (163)
Optical Coherence Tomography (OCT): Imaging the Visual Pathway as a Model for Neurodegeneration (2010) (160)
Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability. (2009) (153)
A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis (2021) (145)
A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis (2008) (141)
Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord. (2009) (141)
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL (2009) (139)
NMDA Receptor Signaling in Oligodendrocyte Progenitors Is Not Required for Oligodendrogenesis and Myelination (2011) (137)
Axonal Protective Effects of the Myelin-Associated Glycoprotein (2009) (136)
Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis. (2015) (133)
Characterization of MRI response to treatment with interferon beta-1b: Contrast-enhancing MRI lesion frequency as a primary outcome measure (1997) (132)
Cell-based therapeutic strategies for multiple sclerosis (2017) (128)
The utility of MRI in suspected MS (2003) (128)
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis (2007) (127)
Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis. (2008) (127)
Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators. (2004) (126)
DeepHarmony: A deep learning approach to contrast harmonization across scanner changes. (2019) (124)
VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta (1997) (123)
IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. (2005) (121)
Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: A pilot study (2009) (119)
Human iPSC-derived blood-brain barrier microvessels: validation of barrier function and endothelial cell behavior. (2019) (117)
PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R) (2019) (116)
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics. (2014) (115)
The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility (2017) (113)
Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS (1998) (113)
Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease. (2005) (109)
Revisiting Brain Atrophy and Its Relationship to Disability in Multiple Sclerosis (2012) (107)
Quantitative characterization of the corticospinal tract at 3T. (2006) (106)
Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis (2006) (102)
Reproducibility of high-resolution optical coherence tomography in multiple sclerosis (2010) (101)
Behavioral and pathological outcomes in MOG 35–55 experimental autoimmune encephalomyelitis (2008) (98)
Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis. (2012) (98)
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2018) (98)
Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging (2016) (97)
Characterization of the Functional Properties of the Voltage-Gated Potassium Channel Kv1.3 in Human CD4+ T Lymphocytes1 (2007) (97)
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica (2013) (97)
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE (2015) (97)
Probing mouse brain microstructure using oscillating gradient diffusion MRI (2012) (96)
The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. (2004) (96)
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL (2009) (94)
Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis (2007) (90)
High b‐value q‐space diffusion‐weighted MRI of the human cervical spinal cord in vivo: Feasibility and application to multiple sclerosis (2008) (86)
Neuropsychiatric syndromes of multiple sclerosis (2017) (86)
Interferon-&bgr;-1b slows progression of atrophy in RRMS: Three-year follow-up in NAb− and NAb+ patients (2004) (85)
Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis. (2008) (85)
OASIS is Automated Statistical Inference for Segmentation, with applications to multiple sclerosis lesion segmentation in MRI☆ (2013) (84)
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy (2009) (84)
Decreased microglial activation in MS patients treated with glatiramer acetate (2012) (84)
Volumetric Analysis from a Harmonized Multisite Brain MRI Study of a Single Subject with Multiple Sclerosis (2017) (83)
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial (2019) (83)
An open-label trial of combination therapy with interferon β-1a and oral methotrexate in MS (2002) (82)
Idiopathic transverse myelitis (2007) (82)
Reproducibility of optical coherence tomography in multiple sclerosis. (2008) (82)
Photoreceptor layer thinning in idiopathic Parkinson's disease (2014) (82)
Longitudinal changes in diffusion tensor–based quantitative MRI in multiple sclerosis (2011) (81)
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders (2019) (81)
Corticospinal Tract Abnormalities Are Associated with Weakness in Multiple Sclerosis (2008) (81)
Increased serum levels of soluble CD95 (APO‐1/Fas) in relapsing‐remitting multiple sclerosis (1998) (80)
Interferon beta results in immediate reduction of contrast‐enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI (1997) (80)
Interleukin-17 in transverse myelitis and multiple sclerosis (2008) (79)
Transfer of Myelin-Reactive Th17 Cells Impairs Endogenous Remyelination in the Central Nervous System of Cuprizone-Fed Mice (2015) (78)
In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques (2012) (77)
Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS (2009) (77)
Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis (2013) (77)
Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis (2013) (74)
In vivo and ex vivo diffusion tensor imaging of cuprizone‐induced demyelination in the mouse corpus callosum (2012) (73)
Multiple Sclerosis Lesion Segmentation from Brain MRI via Fully Convolutional Neural Networks (2018) (73)
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis (2016) (73)
Potassium channels Kv1.3 and Kv1.5 are expressed on blood‐derived dendritic cells in the central nervous system (2006) (71)
Magnetic susceptibility contrast variations in multiple sclerosis lesions (2016) (70)
Investigating Axonal Damage in Multiple Sclerosis by Diffusion Tensor Spectroscopy (2012) (70)
Reproducibility of tract‐specific magnetization transfer and diffusion tensor imaging in the cervical spinal cord at 3 tesla (2009) (69)
Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients (2011) (68)
Retinal Ganglion Cell Layer Volumetric Assessment by Spectral-Domain Optical Coherence Tomography in Multiple Sclerosis: Application of a High-Precision Manual Estimation Technique (2011) (67)
Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis (2015) (67)
Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study (2019) (67)
The Impact of Utilizing Different Optical Coherence Tomography Devices for Clinical Purposes and in Multiple Sclerosis Trials (2011) (66)
Automatic segmentation of microcystic macular edema in OCT. (2014) (66)
Cytokine gene expression in cells derived from CSF of multiple sclerosis patients (1998) (66)
Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone‐induced demyelination (2017) (66)
Evaluating White Matter Lesion Segmentations with Refined Sørensen-Dice Analysis (2020) (65)
Potassium Channel Modulation by a Toxin Domain in Matrix Metalloprotease 23* (2009) (65)
Kv1.3 Deletion Biases T Cells toward an Immunoregulatory Phenotype and Renders Mice Resistant to Autoimmune Encephalomyelitis (2012) (65)
Pulsed magnetization transfer imaging with body coil transmission at 3 Tesla: Feasibility and application (2006) (64)
Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation. (2017) (62)
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod (2012) (62)
Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis. (2008) (62)
Considerations in the treatment of relapsing-remitting multiple sclerosis (2002) (61)
A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation (2014) (61)
Emerging Applications of Optical Coherence Tomography Angiography (OCTA) in neurological research (2018) (61)
Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation (2019) (60)
Quantitative measures detect sensory and motor impairments in multiple sclerosis (2011) (59)
Outer retinal changes following acute optic neuritis (2016) (59)
One eye or two: a comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis. (2011) (59)
Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis (2009) (59)
Signal Transduction Inhibition of APCs Diminishes Th17 and Th1 Responses in Experimental Autoimmune Encephalomyelitis1 (2009) (59)
Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83–99) (1996) (58)
MRI studies of multiple sclerosis: Implications for the natural history of the disease and for monitoring effectiveness of experimental therapies (1996) (58)
APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies (2021) (56)
Targeting repulsive guidance molecule A to promote regeneration and neuroprotection in multiple sclerosis. (2015) (56)
Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study (2020) (56)
Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning (2020) (56)
Granzyme B mediates neurotoxicity through a G‐protein‐coupled receptor (2006) (56)
Anti-CD20 therapy depletes activated myelin-specific CD8+ T cells in multiple sclerosis (2019) (55)
Diffusion Tensor Imaging of the Optic Tracts in Multiple Sclerosis: Association with Retinal Thinning and Visual Disability (2011) (54)
Disease-modifying therapies modulate retinal atrophy in multiple sclerosis (2017) (54)
1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization (2013) (54)
A lipid storage–like disorder contributes to cognitive decline in HIV-infected subjects (2013) (54)
Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS (2012) (54)
Dimethyl fumarate alters B‐cell memory and cytokine production in MS patients (2017) (54)
q‐space and conventional diffusion imaging of axon and myelin damage in the rat spinal cord after axotomy (2010) (53)
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis (2010) (53)
Automated vs. conventional tractography in multiple sclerosis: Variability and correlation with disability (2010) (53)
Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis (2012) (52)
New and emerging disease modifying therapies for multiple sclerosis (2012) (52)
Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination (2015) (52)
Remyelination alters the pattern of myelin in the cerebral cortex (2020) (51)
Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity (2016) (51)
Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy (2021) (50)
Mesenchymal Stem Cells Differentially Modulate Effector CD8+ T Cell Subsets and Exacerbate Experimental Autoimmune Encephalomyelitis (2014) (50)
Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis (2015) (50)
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a (2009) (50)
Interferon-β-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis (2005) (50)
Applications of a deep learning method for anti-aliasing and super-resolution in MRI. (2019) (50)
AQP4-IgG and MOG-IgG Related Optic Neuritis—Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis (2020) (49)
Retinal damage and vision loss in African American multiple sclerosis patients (2015) (49)
Thalamic lesions in multiple sclerosis by 7T MRI: Clinical implications and relationship to cortical pathology (2015) (49)
Diffusion Tensor Imaging of the Optic Nerve in Multiple Sclerosis: Association with Retinal Damage and Visual Disability (2011) (49)
Cutting Edge: The Transcription Factor Kruppel-Like Factor 4 Regulates the Differentiation of Th17 Cells Independently of RORγt (2010) (48)
Activated T-Cells Inhibit Neurogenesis by Releasing Granzyme B: Rescue by Kv1.3 Blockers (2010) (48)
Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study (2018) (47)
PEGylation of Interferon-β-1a (2012) (47)
Towards Topological Correct Segmentation of Macular OCT from Cascaded FCNs (2017) (47)
Cleavage of myelin associated glycoprotein by matrix metalloproteinases (2008) (46)
Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy (2020) (46)
Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis (2013) (46)
Ekbom's syndrome: Lipomas, ataxia, and neuropathy with MERRF (1994) (46)
KLF4 Modulates Expression of IL-6 in Dendritic Cells via Both Promoter Activation and Epigenetic Modification* (2013) (46)
Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis (2013) (46)
Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measures (2019) (46)
Agar-gelatin for embedding tissues prior to paraffin processing. (2007) (46)
Alu insertion variants alter mRNA splicing (2018) (46)
Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis (2018) (46)
Multiple-object geometric deformable model for segmentation of macular OCT. (2014) (45)
Metabolomics in multiple sclerosis (2016) (44)
SMORE: A Self-Supervised Anti-Aliasing and Super-Resolution Algorithm for MRI Using Deep Learning (2020) (44)
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica (2015) (43)
FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway (2014) (43)
Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy (2021) (43)
Fully Convolutional Boundary Regression for Retina OCT Segmentation (2019) (42)
Visual Pathway Axonal Loss in Benign Multiple Sclerosis: A Longitudinal Study (2012) (42)
Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis (2014) (42)
Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis (2019) (42)
The Impact of Dynamic Balance Measures on Walking Performance in Multiple Sclerosis (2015) (41)
Chemokine receptor expression on MBP-reactive T cells: CXCR6 is a marker of IFNγ-producing effector cells (2002) (40)
Imaging outcome measures of neuroprotection and repair in MS (2019) (40)
Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials (2015) (40)
T lymphocytes conditioned with Interferon β induce membrane and soluble VCAM on human brain endothelial cells (2001) (39)
Granzyme B-Induced Neurotoxicity Is Mediated via Activation of PAR-1 Receptor and Kv1.3 Channel (2012) (39)
MIMoSA: An Automated Method for Intermodal Segmentation Analysis of Multiple Sclerosis Brain Lesions (2018) (39)
Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis (2005) (38)
A Comparison of Supervised Machine Learning Algorithms and Feature Vectors for MS Lesion Segmentation Using Multimodal Structural MRI (2014) (38)
Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS) (2012) (38)
Retinal measurements predict 10‐year disability in multiple sclerosis (2019) (37)
Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement. (2019) (37)
Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis. (2014) (36)
Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells (1997) (35)
Complex geometric models of diffusion and relaxation in healthy and damaged white matter (2009) (35)
Quantitative measures of walking and strength provide insight into brain corticospinal tract pathology in multiple sclerosis (2017) (35)
Functional Blockade of the Voltage-gated Potassium Channel Kv1.3 Mediates Reversion of T Effector to Central Memory Lymphocytes through SMAD3/p21cip1 Signaling* (2011) (34)
Axial 3D gradient-echo imaging for improved multiple sclerosis lesion detection in the cervical spinal cord at 3T (2013) (34)
Dimethyl fumarate treatment alters NK cell function in multiple sclerosis (2018) (34)
A Disentangled Latent Space for Cross-Site MRI Harmonization (2020) (34)
Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions? (2017) (34)
Deep learning based topology guaranteed surface and MME segmentation of multiple sclerosis subjects from retinal OCT. (2019) (33)
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2018) (33)
Reconstruction of the human cerebral cortex robust to white matter lesions: Method and validation (2014) (33)
Baseline Retinal Nerve Fiber Layer Thickness and Macular Volume Quantified by OCT in the North American Phase 3 Fingolimod Trial for Relapsing–Remitting Multiple Sclerosis (2013) (33)
Longitudinal relationships among posturography and gait measures in multiple sclerosis (2015) (33)
A Deep Learning Based Anti-aliasing Self Super-Resolution Algorithm for MRI (2018) (32)
PML-IRIS in a patient treated with brentuximab (2012) (32)
Hiding in plain sight: a closer look at posterior cortical atrophy (2014) (32)
Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells. (2013) (32)
Ethics of placebo-controlled clinical trials in multiple sclerosis (2008) (31)
Spinal Cord Normalization in Multiple Sclerosis (2014) (31)
Single-cell transcriptomic reveals molecular diversity and developmental heterogeneity of human stem cell-derived oligodendrocyte lineage cells (2021) (31)
How global MS prevalence is changing: A retrospective chart review in the United Arab Emirates. (2016) (31)
Emerging injectable therapies for multiple sclerosis (2013) (31)
Bystander modulation of chemokine receptor expression on peripheral blood T lymphocytes mediated by glatiramer therapy. (2005) (30)
Diversity and Function of Glial Cell Types in Multiple Sclerosis. (2021) (30)
Retinal layer parcellation of optical coherence tomography images: Data resource for multiple sclerosis and healthy controls (2018) (30)
Bryostatin-1 alleviates experimental multiple sclerosis (2018) (30)
Chemokines in chronic progressive neurological diseases: HTLV-1 associated myelopathy and multiple sclerosis. (1999) (30)
Structured layer surface segmentation for retina OCT using fully convolutional regression networks (2020) (30)
Longitudinal multiple sclerosis lesion segmentation data resource (2017) (29)
Randomized controlled trial of atorvastatin in clinically isolated syndrome (2012) (29)
Analysis of macular OCT images using deformable registration. (2014) (29)
Unmasking of autoimmune hepatitis in a patient with MS following interferon beta therapy (2006) (28)
Gradient nonlinearity effects on upper cervical spinal cord area measurement from 3D T1‐weighted brain MRI acquisitions (2018) (28)
20/40 or Better Visual Acuity After Optic Neuritis: Not as Good as We Once Thought? (2015) (28)
Expression of CCR7 and CD45RA in CD4+ and CD8+ subsets in cerebrospinal fluid of 134 patients with inflammatory and non-inflammatory neurological diseases (2012) (28)
Intensity warping for multisite MRI harmonization (2019) (27)
Comparative Study of the Presence of Chlamydia pneumoniae in Cerebrospinal Fluid of Patients with Clinically Definite and Monosymptomatic Multiple Sclerosis (2002) (27)
Dendritic cells are abundant in non-lesional gray matter in multiple sclerosis. (2007) (27)
Segmentation of retinal OCT images using a random forest classifier (2013) (27)
ELI-spot of Th-1 cytokine secreting PBMC's in multiple sclerosis: correlation with MRI lesions (1998) (26)
Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes (2018) (26)
Quantitative sensory and motor measures detect change overtime and correlate with walking speed in individuals with multiple sclerosis. (2015) (26)
Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition (2020) (26)
Impaired renal function in progressive multiple sclerosis (2002) (26)
Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+ T Effector Memory Lymphocytes (2013) (26)
Synaptic and complement markers in extracellular vesicles in multiple sclerosis (2020) (25)
Retinal architecture predicts pupillary reflex metrics in MS (2009) (25)
Immune cell modulation of oligodendrocyte lineage cells (2019) (25)
The expanding spectrum of aetiologies causing retinal microcystic macular change. (2013) (25)
Optimal Inter-Eye Difference Thresholds by OCT in MS: An International Study (2019) (25)
B-Cell Depletion - A Frontier in Monoclonal Antibodies for Multiple Sclerosis. (2017) (25)
Low serum vitamin D levels and recurrent inflammatory spinal cord disease. (2012) (24)
Topology guaranteed segmentation of the human retina from OCT using convolutional neural networks (2018) (24)
An Automated Statistical Technique for Counting Distinct Multiple Sclerosis Lesions (2017) (24)
Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics: A Putative Pathophysiologic Signature for the Retino-Hypothalamic Tract in Multiple Sclerosis (2017) (24)
Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis. (2020) (24)
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: Yes (2014) (24)
Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS (2012) (24)
Association of Spectral-Domain OCT With Long-term Disability Worsening in Multiple Sclerosis (2021) (23)
Spike and-Slab Group LASSOs for Grouped Regression and Sparse Generalized Additive Models (2019) (23)
Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis (2020) (23)
Avonex Combination Trial in relapsing—remitting MS: rationale, design and baseline data (2008) (23)
Associations between retinal nerve fiber layer abnormalities and optic nerve examination (2010) (23)
Information-based Disentangled Representation Learning for Unsupervised MR Harmonization (2021) (23)
Combined registration and motion correction of longitudinal retinal OCT data (2016) (22)
Early complement genes are associated with visual system degeneration in multiple sclerosis. (2019) (22)
Daclizumab-induced adverse events in multiple organ systems in multiple sclerosis (2014) (22)
Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation (2021) (22)
Thalamus segmentation using multi-modal feature classification: Validation and pilot study of an age-matched cohort (2017) (22)
Efficacy Results from the Phase 2b SYNERGY Study: Treatment of Disabling Multiple Sclerosis with the Anti-LINGO-1 Monoclonal Antibody Opicinumab (S33.004) (2017) (22)
Diffusion‐time dependence of diffusional kurtosis in the mouse brain (2020) (21)
Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial (2017) (21)
Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis. (2020) (21)
Novel therapies for memory cells in autoimmune diseases (2015) (21)
Multisite reliability and repeatability of an advanced brain MRI protocol (2019) (21)
FLT3 inhibitors for the treatment of autoimmune disease (2008) (21)
Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain Atrophy (2020) (20)
Health Effects of Lesion Localization in Multiple Sclerosis: Spatial Registration and Confounding Adjustment (2014) (20)
Clay-shoveler's fracture during indoor rock climbing. (2013) (20)
Detection of clinical and subclinical retinal abnormalities in neurosarcoidosis with optical coherence tomography (2012) (20)
419 – Multiple Sclerosis and Demyelinating Conditions of the Central Nervous System (2011) (20)
iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu (2020) (19)
The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States (2020) (19)
Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism (2021) (19)
Natalizumab: bound to rebound? (2009) (18)
IL-6 release by LPS-stimulated peripheral blood mononuclear cells as a potential biomarker in Alzheimer's disease (2009) (18)
Simultaneous segmentation of retinal surfaces and microcystic macular edema in SDOCT volumes (2016) (18)
NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunity (2019) (18)
Memory lineage relationships in HTLV-1-specific CD8+ cytotoxic T cells (2006) (17)
OCT Retinal Nerve Fiber Layer Thickness Differentiates Acute Optic Neuritis from MOG Antibody-Associated Disease and Multiple Sclerosis (2022) (17)
Relation of quantitative visual and neurologic outcomes to fatigue in multiple sclerosis. (2015) (17)
Microcystic macular edema detection in retina OCT images (2014) (17)
Inhibition of neutral sphingomyelinase 2 promotes remyelination (2020) (16)
Impaired toll-like receptor 8 signaling in multiple sclerosis (2013) (16)
Retrograde trans-synaptic visual pathway degeneration in multiple sclerosis: A case series (2017) (16)
Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study (2021) (16)
Cup to disc ratio by optical coherence tomography is abnormal in multiple sclerosis (2011) (16)
Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis. (2013) (16)
Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study (2014) (16)
Topologically Constrained Segmentation of Brain Images with Multiple Sclerosis Lesions (2008) (16)
Visual Pathway Measures are Associated with Neuropsychological Function in Multiple Sclerosis (2018) (15)
Future research directions in multiple sclerosis therapies. (2008) (15)
FLT-3 expression and function on microglia in multiple sclerosis. (2010) (15)
Longitudinal assessment of hand function in individuals with multiple sclerosis. (2019) (15)
Artificial intelligence extension of the OSCAR‐IB criteria (2021) (15)
An adaptive grid for graph-based segmentation in retinal OCT (2014) (15)
Kinetics of CCR7 expression differ between primary activation and effector memory states of TH1 and TH2 cells (2003) (15)
Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring (2020) (15)
Optical Coherence Tomography in Neurologic Diseases (2015) (15)
Diagnosis and classification of optic neuritis (2022) (14)
Comparison of Point Estimates and Average Thicknesses of Retinal Layers Measured Using Manual Optical Coherence Tomography Segmentation for Quantification of Retinal Neurodegeneration in Multiple Sclerosis (2013) (14)
Deformable registration of macular oct using a-mode scan similarity (2013) (14)
Association of body mass index with longitudinal rates of retinal atrophy in multiple sclerosis (2020) (14)
Distinguishing among multiple sclerosis fallers, near-fallers and non-fallers. (2018) (14)
Week 144 Results of a Phase II, Randomized, Multicenter Trial Assessing the Safety and Efficacy of Ocrelizumab in Patients with Relapsing–Remitting Multiple Sclerosis (RRMS) (S31.004) (2013) (14)
Thalamus parcellation using multi-modal feature classification and thalamic nuclei priors (2016) (14)
Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology (2010) (13)
Segmentation of microcystic macular edema in Cirrus OCT scans with an exploratory longitudinal study (2015) (13)
Optical coherence tomography: A quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosis (2017) (13)
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod. (2013) (13)
Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis (2022) (13)
Long-Term Efficacy and Safety of Fingolimod (FTY720) in Relapsing-Remitting Multiple Sclerosis (RRMS): Results from the Extension of the Phase III FREEDOMS Study (S41.004) (2012) (13)
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2020) (13)
Defining response profiles after alemtuzumab (2018) (13)
Quantitative MRI Demonstrates Abnormality of the Fornix and Cingulum in Multiple Sclerosis (2013) (13)
Deep Harmonization of Inconsistent MR Data for Consistent Volume Segmentation (2018) (13)
Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis. (2016) (12)
Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial (2021) (12)
Macular Ganglion Cell and Inner Plexiform Layer Thickness Is More Strongly Associated With Visual Function in Multiple Sclerosis Than Bruch Membrane Opening-Minimum Rim Width or Peripapillary Retinal Nerve Fiber Layer Thicknesses. (2019) (12)
Brief Report: Anti–Calponin 3 Autoantibodies: A Newly Identified Specificity in Patients With Sjögren’s Syndrome (2018) (12)
Optic nerve head component responses of the multifocal electroretinogram in MS (2013) (12)
The International Multiple Sclerosis Visual System Consortium: Advancing Visual System Research in Multiple Sclerosis (2018) (12)
Layer boundary evolution method for macular OCT layer segmentation. (2019) (12)
Evidence of subclinical quantitative retinal layer abnormalities in AQP4-IgG seropositive NMOSD (2020) (12)
Kv1.3 Potassium Channel: Physiology, Pharmacology and Therapeutic Indications (2006) (12)
Objective characterization of the relative afferent pupillary defect in MS (2012) (12)
The diagnosis of MS (2008) (12)
Optical Coherence Tomography and Optical Coherence Tomography Angiography Findings After Optic Neuritis in Multiple Sclerosis (2020) (11)
Analysis of Agreement of Retinal-Layer Thickness Measures Derived from the Segmentation of Horizontal and Vertical Spectralis OCT Macular Scans (2018) (11)
Longitudinal graph-based segmentation of macular OCT using fundus alignment (2015) (11)
Accelerated axon loss in MOG35-55 experimental autoimmune encephalomyelitis (EAE) in myelin-associated glycoprotein-deficient (MAGKO) mice (2013) (11)
Therapeutic Application of Monoclonal Antibodies in Multiple Sclerosis (2017) (11)
Increased TNFR1 expression and signaling in injured peripheral nerves of mice with reduced BACE1 activity (2016) (11)
CNS-targeted autoimmunity leads to increased influenza mortality in mice (2017) (11)
Serum ceramide levels are altered in multiple sclerosis (2020) (11)
Variational intensity cross channel encoder for unsupervised vessel segmentation on OCT angiography (2020) (10)
Antigenic Stimulation of Kv1.3-Deficient Th Cells Gives Rise to a Population of Foxp3-Independent T Cells with Suppressive Properties (2015) (10)
The NAIMS cooperative pilot project: Design, implementation and future directions (2018) (10)
Dice Overlap Measures for Objects of Unknown Number: Application to Lesion Segmentation (2017) (10)
Multi-layer fast level set segmentation for macular OCT (2018) (10)
Phenytoin in acute optic neuritis: neuroprotective or not? (2016) (10)
Fingolimod-Effect on Brain Atrophy and Clinical/MRI Correlations in Three Phase 3 Studies – TRANSFORMS, FREEDOMS and FREEDOMS II (S51.006) (2013) (10)
Stratus OCT Quality Control in Two Multi-Centre Multiple Sclerosis Clinical Trials (2011) (10)
Pain, cognition and quality of life associate with structural measures of brain volume loss in multiple sclerosis. (2016) (10)
Quetiapine has an additive effect to triiodothyronine in inducing differentiation of oligodendrocyte precursor cells through induction of cholesterol biosynthesis (2019) (10)
Microvascular blood flow velocities measured with a retinal function imager: inter-eye correlations in healthy controls and an exploration in multiple sclerosis (2018) (10)
Multiple sclerosis: Can retinal imaging accurately detect optic neuritis? (2010) (9)
Longitudinal intensity normalization in the presence of multiple sclerosis lesions (2013) (9)
Spinal cord and infratentorial lesions in radiologically isolated syndrome are associated with decreased retinal ganglion cell/inner plexiform layer thickness (2018) (9)
Contribution of B cells to cortical damage in multiple sclerosis. (2022) (9)
1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controls (2015) (9)
Erratum: The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS (Journal of Clinical Investigation (2003) 111 (1703-1713)) (2003) (8)
Multiple Sclerosis (2016) (8)
Development of a Highly Sensitive Neurofilament Light Chain Assay on an Automated Immunoassay Platform (2022) (8)
Optical coherence tomography in x-linked adrenoleukodystrophy. (2013) (8)
Retinal architecture and mfERG (2014) (8)
Disentangled Representation Learning for OCTA Vessel Segmentation With Limited Training Data (2022) (7)
Voxel based morphometry in optical coherence tomography: validation and core findings (2016) (7)
Joint Intensity Fusion Image Synthesis Applied to Multiple Sclerosis Lesion Segmentation (2017) (7)
Intensity inhomogeneity correction of macular OCT using N3 and retinal flatspace (2016) (7)
Monitoring diffuse injury during disease progression in experimental autoimmune encephalomyelitis with on resonance variable delay multiple pulse (onVDMP) CEST MRI (2020) (7)
Erratum: The efficacy of natalizumab in patients with relapsing multiple sclerosis: Subgroup analyses of AFFIRM and SENTINEL (Journal of Neurology (2009) 256 (405-415) DOI: 10.1007/s00415-009-0093-1) (2009) (7)
Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune Encephalomyelitis (2021) (7)
Adversarial domain adaptation for multi-device retinal OCT segmentation (2020) (7)
Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning. (2016) (7)
Contributors to Serum NfL Levels in People without Neurologic Disease (2022) (7)
Longitudinal Retinal Changes in MOGAD (2022) (7)
Promising treatments of tomorrow for multiple sclerosis (2009) (6)
From neurofilament research to multiple sclerosis clinical practice (2017) (6)
The Role of Optical Coherence Tomography Criteria and Machine Learning in Multiple Sclerosis and Optic Neuritis Diagnosis (2022) (6)
CHAPTER 24 – Inflammatory and Demyelinating Disorders (2009) (6)
Long-Term Safety of Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: Results from Phase 3 FREEDOMS II Extension Study (P01.165) (2013) (6)
Glutamine antagonism attenuates physical and cognitive deficits in a model of MS (2019) (6)
Projection Artifact Suppression For Inner Retina In Oct Angiography (2019) (6)
MIMoSA: A Method for Inter-Modal Segmentation Analysis (2017) (5)
Corneal confocal microscopy demonstrates axonal loss in different courses of multiple sclerosis (2021) (5)
High-dose vitamin D supplementation reduces IL-17-producing CD4+ T-cells and effector-memory CD4+ T-cells in multiple sclerosis patients (S38.001) (2015) (5)
ADVANCE Phase 3 Study of PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis: Patient Baseline Characteristics (P01.133) (2012) (5)
Modulation of Retinal Atrophy With Rituximab in Multiple Sclerosis (2021) (5)
Clinical Efficacy and Safety of Peginterferon beta-1a in Relapsing Multiple Sclerosis: Data from the Pivotal Phase 3 ADVANCE Study (S31.006) (2013) (5)
Proteomic Alterations and Novel Markers of Neurotoxic Reactive Astrocytes in Human Induced Pluripotent Stem Cell Models (2022) (5)
Intensity inhomogeneity correction of SD‐OCT data using macular flatspace (2018) (5)
Retinal Oximetry-Derived Biomarkers of Metabolic Dysfunction in MS (P5.307) (2015) (5)
Measuring treatment response to advance precision medicine for multiple sclerosis (2021) (5)
Inflammation in multiple sclerosis--sorting out the gray matter. (2011) (5)
Central vein sign in multiple sclerosis (2018) (5)
Long-Term Efficacy and Safety of Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Week 96 Results of a Phase II, Randomized, Multicenter Trial (S30.006) (2012) (5)
Quantitative vibratory sensation measurement is related to sensory cortical thickness in MS (2019) (4)
TAPAS: A Thresholding Approach for Probability Map Automatic Segmentation in Multiple Sclerosis (2019) (4)
Five-year longitudinal changes in quantitative spinal cord MRI in multiple sclerosis (2020) (4)
Serum Neurofilament Light (NfL): Towards a Blood Test for Prognosis and Disease/Treatment Monitoring in Multiple Sclerosis Patients (S24.003) (2018) (4)
Cerebellar Contributions to Motor and Cognitive Control in Multiple Sclerosis. (2023) (4)
Oligodendrocyte Precursor Cells Are Co-Opted by the Immune System to Cross-Present Antigen and Mediate Cytotoxicity (2018) (4)
Voxel-wise displacement as independent features in classification of multiple sclerosis (2013) (4)
Peptidylarginine Deiminase 2 Autoantibodies Are Linked to Less Severe Disease in Multiple Sclerosis and Post-treatment Lyme Disease (2022) (4)
Segmenting retinal OCT images with inter-B-scan and longitudinal information (2020) (4)
Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis? (2012) (4)
In vivo demonstration of homonymous hemimacular loss of retinal ganglion cells due to a thalamic lesion using optical coherence tomography. (2013) (4)
From the prodromal stage of multiple sclerosis to disease prevention (2022) (4)
OPL100 The effects of natalizumab on disability progression as measured by the Multiple Sclerosis Functional Composite (MSFC) and visual function in patients with relapsing MS (2005) (4)
Fingolimod Reduces Annualized Relapse Rate in Patients with Relapsing-Remitting Multiple Sclerosis: FREEDOMS II Study Subgroup Analysis (P07.102) (2013) (4)
Improving the efficacy of exome sequencing at a quaternary care referral centre: novel mutations, clinical presentations and diagnostic challenges in rare neurogenetic diseases (2021) (4)
Combining Magnetization Transfer Ratio MRI and Quantitative Measures of Walking Improves the Identification of Fallers in MS (2020) (3)
Proof of concept studies for tissue-protective agents in multiple sclerosis (2009) (3)
Intensity standardization of longitudinal images using 4D clustering (2013) (3)
Normative Data and Conversion Equation for Spectral-Domain Optical Coherence Tomography in an International Healthy Control Cohort (2022) (3)
Corrigendum to “Statistical normalization techniques for magnetic resonance imaging” [NeuroImage: Clinical 6 (2014) 9–19] (2015) (3)
Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase 1 trial (Annals of Neurology (2007) (399-495)) (2008) (3)
Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple Sclerosis (2022) (3)
Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core Findings (2021) (2)
Optical coherence tomography in neurological diseases (2015) (2)
Comparison of Retinal Nerve Fiber Layer Thickness and Macular Thickness/Volume Among Patients with Relapsing-Remitting Multiple Sclerosis: Baseline Data from a Phase 3 Trial of Fingolimod (2011) (2)
Fiber tractogrophy and tract segmentation in multiple sclerosis lesions (2011) (2)
Mitochondrial measures in neuronally enriched extracellular vesicles predict brain and retinal atrophy in multiple sclerosis (2022) (2)
Retinal pathology in spontaneous opticospinal experimental autoimmune encephalitis mice (2022) (2)
Dectin-1 signaling on colonic γδ T cells promotes psychosocial stress responses (2023) (2)
Interferon-ß-1b: Prophylactic therapy in multiple sclerosis (2001) (2)
Socioeconomic disparity is associated with faster retinal neurodegeneration in multiple sclerosis. (2021) (2)
Reactive Astrocytes Derived From Human Induced Pluripotent Stem Cells Suppress Oligodendrocyte Precursor Cell Differentiation (2022) (2)
Retinal pathology occurs in stiff-person syndrome (2020) (2)
Overall Disability Response Score: An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosis (2022) (2)
Normalization Techniques for Statistical Inference from Magnetic Resonance Imaging (2013) (2)
Natalizumab increases the proportion of patients free of clinical or MRI disease activity in relapsing multiple sclerosis (2008) (2)
Investigating glatiramer acetate for relapsing–remitting multiple sclerosis at the double dose—is more better? (2007) (2)
Slice Profile Estimation From 2D MRI Acquisition Using Generative Adversarial Networks (2021) (2)
The emergence of neuroepidemiology, neurovirology and neuroimmunology: the legacies of John F. Kurtzke and Richard ‘Dick’ T. Johnson (2017) (2)
Phase 2 AFFINITY trial evaluates opicinumab in a targeted population of patients with relapsing multiple sclerosis: rationale, design and baseline characteristics (2018) (2)
Reply to “Retinal INL Thickness in Multiple Sclerosis: A Mere Marker of Neurodegeneration?” (2020) (2)
Multiple Sclerosis Lesion Segmentation Using Joint Label Fusion (2017) (2)
Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease (2022) (2)
Introduction to optical coherence tomography in neurological diseases (2015) (2)
BRAIN LETTER TO THE EDITOR Reply: Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography (2011) (2)
Cross-Platform Comparison of Retinal Neuronal Layers in Multiple Sclerosis Utilizing a Novel Open-Source Optical Coherence Tomography Automated Segmentation Algorithm (P2.256) (2014) (2)
Global metabolomics identifies perturbation of multiple metabolic pathways in Multiple Sclerosis (P5.242) (2015) (2)
Longitudinal Changes in Quantitative Spinal Cord MRI in Multiple Sclerosis Patients: Results of a 5-year Study (S47.001) (2018) (2)
Associations of sNfL with clinico‐radiological measures in a large MS population (2022) (2)
Breaking the barriers to remyelination in multiple sclerosis. (2022) (2)
Basic principles of optical coherence tomography (2015) (2)
Blockade of Kv1.3 Potassium Channels Inhibits Granzyme B Production in Human Cd8+ T Lymphocytes (2006) (2)
Meta-analysis of optical coherence tomography in multiple sclerosis (2015) (2)
Predictors of an Opicinumab Treatment Effect and Identification of an Efficacy Subpopulation: A Post hoc Analysis of the SYNERGY Study (P3.408) (2018) (2)
Modeling Leptomeningeal Inflammation in EAE - A New Method to Understand Its Pathophysiology and Screen Potential Therapies for Progressive MS (S2.006) (2016) (2)
Optimal Inter-Eye Difference Thresholds in Retinal Nerve Fiber Layer and Ganglion Cell Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis: An International Collaborative Study (P2.160) (2018) (1)
Inter-scanner variation independent descriptors for constrained diffeomorphic demons registration of retina OCT (2018) (1)
RNFL as a Surrogate Outcome Marker in Patients with Multiple Sclerosis: Design of the OCTiMS study, Baseline Characteristics and OCT Test Reproducibility (P7.224) (2015) (1)
T cells in vitro in multiple sclerosis patients and healthy controls (2015) (1)
Multisite MRI reproducibility of lateral ventricular volume using the NAIMS cooperative pilot dataset (2022) (1)
Multiple Sclerosis: Approaches to Early Diagnosis and New Treatment Options (2005) (1)
In-Vivo Assessment of Retinal Neuronal Layers in Multiple Sclerosis with Manual and Automated Optical Coherence Tomography Segmentation Techniques (S10.003) (2012) (1)
Comparison of Cirrus and Spectralis Optical Coherence Tomography: Factors Associated With Differences in Retinal Nerve Fiber Thickness Measurement (P5.312) (2015) (1)
Detection of Clinical and Subclinical Retinal Abnormalities in Neurosarcoidosis with Optical Coherence Tomography (S08.001) (2012) (1)
Diffusion Tensor and Magnetization Transfer Imaging Correlates of Motor Dysfunction in the Spinal Cord in Multiple Sclerosis (S21.002) (2012) (1)
Trials and tribulations on the path to remyelination (2021) (1)
Type of serum collection tube does not impact neurofilament light chain levels. (2022) (1)
2014 Joint ACTRIMS-ECTRIMS Meeting (MSBoston 2014) MS Journal Online: Poster Session 1 (2014) (1)
Characteristics of morphologic macular abnormalities in neuroimmunology practice (2019) (1)
Evaluation of cell transplant-mediated attenuation of diffuse injury in experimental autoimmune encephalomyelitis using onVDMP CEST MRI (2020) (1)
Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS) (2012) (1)
Reply: Photoreceptor layer thinning is not specific for Parkinson's disease (2014) (1)
Is my MS patient failing treatment? (2016) (1)
Differentiating NMO and MS-Associated Optic Neuritis by MRI (S63.002) (2014) (1)
Visual Pathway Structure and Function, Optic Neuritis and Fatigue in Multiple Sclerosis. (S39.008) (2014) (1)
Effect of Fingolimod in Patients with No Disability as Measured by EDSS at Baseline: Post-Hoc Analyses of FREEDOMS I and II (P07.124) (2013) (1)
Author response. (2014) (1)
Trans‐Synaptic Degeneration Following Acute Optic Neuritis in Multiple Sclerosis (2022) (1)
Robust maximum likelihood estimation in Q-space MRI (2008) (1)
The Effect of Axonal "Beading" on Water Diffusion Properties: A Monte Carlo Simulation of Axonal Degeneration and its Effects on DTI Contrasts (2009) (1)
A Novel Diagnostic Tool for Myasthenia Gravis : Ocular Vestibular Evoked Myogenic Potentials (2015) (1)
Effect of GBCA Use on Detection and Diagnostic Performance of the Central Vein Sign: Evaluation Using a 3T FLAIR* Sequence in Patients With Suspected Multiple Sclerosis. (2022) (1)
Peripheral T-Cells, B-Cells, and Monocytes from Multiple Sclerosis Patients Supplemented with High-Dose Vitamin D Show Distinct Changes in Gene Expression Profiles (2022) (1)
Safety, Tolerability and Patient Evaluation of Peginterferon beta-1a Administered Via a Single-Use Autoinjector in Relapsing Multiple Sclerosis: Data from the Phase 3 ATTAIN Study (P01.167) (2013) (1)
The incidence and clinical significance of antibodies to natalizumab over 2 years of treatment in patients with multiple sclerosis (2006) (1)
Ultra-high-field (7.0 Tesla and above) MRI is now necessary to make the next step forward in understanding MS pathophysiology – Commentary (2017) (1)
Advances in multiple sclerosis: from reduced relapses to remedies (2018) (1)
Anti-interleukin-2 receptor alpha for multiple sclerosis? (2013) (1)
2004 Pathogenesis of Rare Neuroimmunologic Disorders, Hyatt Regency Inner Harbor, Baltimore, MD, August 19th 2004–August 20th 2004 (2005) (1)
Impaired toll-like receptor 8 signaling in multiple sclerosis (2013) (1)
Is Cerebrospinal Fluid Responsible for Innate Immune Cell Activation and Neurotoxicity in Multiple Sclerosis? (2021) (1)
Progressive spinal multiple sclerosis. (1993) (1)
Neuron-oligodendrocyte potassium shuttling at nodes of Ranvier protects against inflammatory demyelination (2023) (1)
Natalizumab improves health-related quality of life in patients with relapsing multiple sclerosis (2006) (1)
Pain in patients with multiple sclerosis: Effects of natalizumab (2008) (1)
Optic Neuritis–Independent Retinal Atrophy in Neuromyelitis Optica Spectrum Disorder (2021) (1)
Erratum: Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics (Brain (2014) 137 (2271-2286) DOI: 10.1093/brain/awu139) (2015) (1)
neuromyelitis optica from multiple sclerosis (2015) (0)
Deriving Clinically Useful Visual Evoked Potential Measurements from 120 Sector Multi-Focal Visual Evoked Potential Sequences (P07.259) (2012) (0)
HACA3: A Unified Approach for Multi-site MR Image Harmonization (2022) (0)
The Optic Nerve Head Component: A Novel Eletrophysiologic Marker of Optic Neuropathy in Multiple Sclerosis and Neuromyelitis Optica (S48.001) (2012) (0)
CYTOKINES AND OTHER INFLAMMATORY MEDIATORS OF AXONAL INJURY (2004) (0)
Acknowledgement to Reviewers (2005) (0)
OCT Quality Control in Two Multi-Center Multiple Sclerosis (MS) Therapeutic Trials (2010) (0)
Reply (2007) (0)
Cortical lesion burden on 7-tesla MRI is associated with cognitive and physical disability in multiple sclerosis (S29.005) (2015) (0)
Effect of Kv1.3 inhibition on T cell development, activation and signaling (135.23) (2010) (0)
Good Vibrations: A Novel Method of Damping Acquired Pendular Nystagmus with Vibration (S19.001) (2014) (0)
A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with Multiple Sclerosis (2019) (0)
Visual Pathway Involvement in NMDA Receptor Encephalitis: A Clinical, Optical Coherence Tomography, and 18-Fluorodeoxyglucose PET/CT Approach. (2022) (0)
Mechanical thrombectomy in patients with stroke due to large vessel occlusion in the anterior circulation and low scale score (2021) (0)
Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis (2022) (0)
Reply to “Interpretation of Longitudinal Changes of the Inner Nuclear Layer in MS” (2022) (0)
Neuroimaging: Evaluating the clinical course and pathology of MS (2009) (0)
Corneal confocal microscopy demonstrates axonal loss in different courses of multiple sclerosis (2021) (0)
Bile Acid Metabolism is Altered in Multiple Sclerosis and Supplementation Leads to Amelioration of Neuroinflammation (S55.002) (2019) (0)
Longitudinal Study of Retinal Ganglion Cell Layer Thickness by OCT in Multiple Sclerosis (S48.003) (2012) (0)
Inter-scanner brain MRI volumetric biases persist even in a harmonized multi-subject study of multiple sclerosis (2022) (0)
Waubant, et al Neurology 2012 (2015) (0)
Revising the Advised Protocol for Optical coherence tomography Study Terminology and Elements (APOSTEL): from recommendations to formal guidelines (2017) (0)
HLA-DRB1*1501 Is Associated with Retinal Deterioration in Multiple Sclerosis (P5.278) (2016) (0)
Foxp 3-Independent T Cells with Suppressive Cells Gives Rise to a Population of Antigenic Stimulation of Kv 1 . 3-Deficient Th (2015) (0)
Food for Thought: A Serving of Food-Inspired Eponyms in Neurologic Practice (P1.296) (2014) (0)
Natalizumab (2009) (0)
Assessment of Multiple Sclerosis Patients with a Known History of Unilateral Optic Neuritis Shows Optic Nerve Head Component Loss in the Fellow Unaffected Eye (S58.004) (2012) (0)
Microcystic Macular Edema in Neuromyelitis Optica Is Associated with Visual Disability and Retinal Axonal and Neuronal Loss (IN4-1.009) (2013) (0)
Emerging Therapies (2018) (0)
Longitudinal assessment of rates of brain and retinal atrophy in African American versus Caucasian American patients with Multiple Sclerosis (S47.003) (2018) (0)
Letter to the editor (1995) (0)
Distinct mechanisms of oligodendrocyte injury inform therapeutic interventions in multiple sclerosis. (2022) (0)
of the Voltage-Gated Potassium Channel Characterization of the Functional Properties (2017) (0)
CEST MRI and MALDI imaging reveal metabolic alterations in the cervical lymph nodes of EAE mice (2022) (0)
Chemokines in chronic progressive neurological associated myelopathy and diseases: mu1 t ip le HTLV-1 sclerosis (1999) (0)
Acknowledgement to reviewers (2004) (0)
Bi-directional Synthesis of Pre- and Post-contrast MRI via Guided Feature Disentanglement (2022) (0)
Retinal Nerve Fiber Layer Thickness defines Multiple Sclerosis Patients at Risk of Future Disease Progression (S33.003) (2017) (0)
Contributors (2012) (0)
Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis (2022) (0)
Visual Function and Optical Coherence Tomography in Pediatric Demyelinating Diseases (P01.158) (2012) (0)
Longitudinal deep network for consistent OCTlayer segmentation (2023) (0)
Exploring the Information Content of q-Space Diffusion Weighted Imaging : Application to Multiple Sclerosis ( MS ) Spinal Cord Lesions (2007) (0)
200 AFFINITY: opicinumab in a targeted population of MS patients (2019) (0)
Amendment history : Erratum ( July 2003 ) The voltage-gated Kv 1 . 3 K + channel in effector memory T cells as new target for MS (2018) (0)
Clinical and Ocular Imaging Characteristics of Eyes With Visual Loss Over Time in Multiple Sclerosis (2009) (0)
Metabolomic Networks Associated with Changes in Cytokine Expression Differ in Multiple Sclerosis Patients and Healthy Controls Following Vitamin D Supplementation (P5.297) (2016) (0)
1,25-dihydroxyvitamin-D3 reversibly prevents EAE by modulating Th cells trafficking without affecting priming or effector functions (P5123) (2013) (0)
, P cytotoxic T cells . susceptibility to lysis by CD 8 + HTLV-1-specific induction of tumor necrosis factor alpha and lymphotropic virus type 1 ( HTLV-1 ) Tax : Astrocyte-specific expression of human T-cell (1997) (0)
Vitreomacular Interface Abnormalities in Multiple Sclerosis; A Novel Signature of Disability (P10-3.013) (2023) (0)
Teaching Video NeuroImage: Dramatic Response to Topiramate in Acquired Pendular Nystagmus From Multiple Sclerosis (2022) (0)
Application of diagnostic criteria for optic neuritis – Authors' reply (2023) (0)
Normalization of the Spinal Cord in Multiple Sclerosis (P06.106) (2013) (0)
Vitamin D Supplementation Reduces Markers of Oxidative Stress Measured by Untargeted Metabolomics in Healthy Controls but Not in Multiple Sclerosis Patients (P3.006) (2016) (0)
Retinal inflammation in multiple sclerosis revealed by optical coherence tomography and ophthalmoscopy (2015) (0)
Retinal Thickness and Visual Disability in Patients with Multiple Sclerosis and Disease-Free Controls with Myopia (S48.008) (2016) (0)
Clinical and Radiological Disease Activity Is Associated with Accelerated Rates of Retinal Ganglion Cell Layer Degeneration in Multiple Sclerosis (S10.002) (2012) (0)
Optical coherence tomography and electrophysiology of the optic nerve head (2015) (0)
Optical coherence tomography and visual outcomes in acute optic neuritis (2015) (0)
Retinal Atrophy Measured by Optical Coherence Tomography Predicts Disability Progression in Multiple Sclerosis (S45.007) (2016) (0)
Vision as a Structural and Functional Correlate to Fatigue and Disability in Multiple Sclerosis (2013) (0)
Dissecting fingolimod’s action: a novel immunomodulatory effect of the unphosphorylated compound on cytotoxic T cell function (P5159) (2013) (0)
Kv1.3 deletion induces Foxo1 expression independently of Foxp3 and biases Th cells toward an immunoregulatory phenotype (P5127) (2013) (0)
Overall Response Score: A Novel Disability Endpoint That Allows for the Integrated Assessment of Improvement and Worsening over Time in Patients with MS (P4.380) (2018) (0)
Multiple Sclerosis Therapeutics: Neuroprotection in multiple sclerosis (2011) (0)
Cortical Lesions In Multiple Sclerosis Correlate With Retinal Pathology As Measured By Optical Coherence Tomography (S54.005) (2014) (0)
Understanding the role of glial cells (astrocytes and oligodendrocytes) in maintaining the homeostasis of the optic nerve (2018) (0)
IMAGING IN MS RELATIVE CLINICAL UTILITY OF QUANTITATIVE MRI MEASURES IN THE SPINAL CORD IN MS PATIENTS (2013) (0)
The Effect of Beading and Permeable Axons on Water Diffusion Properties : A Monte Carlo Simulation of Axonal Degeneration and Its Effect on DTI and Q-space Contrasts (2009) (0)
A Method for Analysis of Cortical Lesions on 7-Tesla MRI in Multiple Sclerosis (P03.064) (2012) (0)
Autoimmune Diminishes Th17 and Th1 Responses in Signal Transduction Inhibition of APCs (0)
Mesenchymal stem cells differentially modulate effector CD8+ T cells and exacerbate EAE. (IRC8P.484) (2014) (0)
The Optic Nerve Head Component of the Multifocal Electroretinogram: A Novel Metric for Dissecting Pathophysiologic Mechanisms in MS (S10.001) (2012) (0)
Neurodegeneration and neuroprotection in multiple sclerosis (2004) (0)
Characterization of Retinal Layer Thickness Changes Using Volumetric SD-OCT Images in a Multiple Sclerosis Mouse Model (2016) (0)
3451 MAGNETIC SUSCEPTIBILITY CONTRAST VARIATIONS IN MULTIPLE SCLEROSIS ( MS ) LESIONS OBSERVED AT 7 T (2013) (0)
Single-Cell Transcriptomic Analysis Reveals Molecular Diversity of Human Oligodendrocyte Progenitor Cells (2020) (0)
CEST MRI and MALDI imaging reveal metabolic alterations in the cervical lymph nodes of EAE mice (2022) (0)
NAIL-ing the Diagnosis: Real Neurologists Pay Attention to the Nails (P1.030) (2014) (0)
Optical coherence tomography in acute optic neuritis (2015) (0)
Retinal neuronal and axonal loss over time as markers of disease progression and activity in Multiple Sclerosis: A pilot study (P5.223) (2015) (0)
Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population (2022) (0)
Interferon beta results in immediate improvement of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI (1996) (0)
Rapid Brain Meninges Surface Reconstruction with Layer Topology Guarantee (2023) (0)
Inhibition of neutral sphingomyelinase-2 facilitates remyelination (2019) (0)
The relationship between disease severity and health-related quality of life in patients with relapsing multiple sclerosis (2006) (0)
OCTiMS Study: A 3-Year Longitudinal Assessment of RNFL Thickness Measured by Optical Coherence Tomography in Patients with Relapsing–Remitting Multiple Sclerosis (S24.001) (2018) (0)
Chemokines in chronic progressive neurological multiple sclerosis (1999) (0)
Relation of Ganglion Cell Layer Thinning to Axonal Loss, Visual Function, and Quality of Life in Multiple Sclerosis (2011) (0)
Safety Profile and Immunologic Effects of High vs. Low-Dose Cholecalciferol in Relapsing-Remitting Multiple Sclerosis: A Randomized Double-Blind Pilot Study (S01.006) (2013) (0)
Optical coherence tomography in a multi-center setting: quality control issues (2015) (0)
Probing Mouse Brain Microstructure Using Oscillating Gradient Diffusion Magnetic Resonance Imaging (2011) (0)
estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived (2011) (0)
Trial of Tauroursodeoxycholic Acid Supplementation in Patients with Progressive MS (S16.007) (2023) (0)
Natalizumab reduces loss of visual function in patients with relapsing multiple sclerosis (2006) (0)
Generic MS medications: Reducing costs without compromising safety (2022) (0)
Functional Knockout of Kv1.3 Channels Suppresses Effector Memory Phenotype Acquisition in Dominant Negative Kv1.3-expressing Human CD4+ T Cells (2007) (0)
Response to—Tracking the role of sphingolipids in MS: The dynamic nature of ceramide synthases (2022) (0)
Effects of Myopia on Rates of Change in Optical Coherence Tomography Measured Retinal Layer Thicknesses in People with Multiple Sclerosis and Healthy Controls (2022) (0)
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica (2015) (0)
Evaluating Retinal Abnormalities in Patients With Multiple Sclerosis—Reply (2010) (0)
Development of a Screening Platform that uses Genome Engineered hPSC-Derived OPCs for the Discovery of Remyelination Promoting Compounds (2020) (0)
Optical Coherence Tomography in Neurologic Diseases: Optical coherence tomography and brain magnetic resonance imaging in multiple sclerosis (2015) (0)
Evaluating White Matter Lesion Segmentations with Refined Sørensen-Dice Analysis (2020) (0)
Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis (2019) (0)
t g of ROR Differentiation of Th17 Cells Independently Kruppel-Like Factor 4 Regulates the Cutting Edge: The Transcription Factor (2010) (0)
MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis (2022) (0)
018 Disease control beyond NEDA: the value of non-clinical measures to determine treatment response to natalizumab (2022) (0)
Complex antibody profiling to predict clinical outcome in childhood ADS (2014) (0)
Imaging Chronic Active Lesions in Multiple Sclerosis: a Consensus Statement from the North America Imaging in Multiple Sclerosis Cooperative (P11-3.009) (2023) (0)
OCT in Relapsing–Remitting Multiple Sclerosis (RRMS) (2016) (0)
MRI Lesion Length in Acute Optic Neuritis Correlates with Degree of Inner Retinal Thinning in Multiple Sclerosis (P2.120) (2016) (0)
CSF from MS Patients Induces Mitochondrial Dysfunction in Unmyelinated Neuronal Cultures (P05.179) (2013) (0)
Decision letter: Microglial SIRPα regulates the emergence of CD11c+ microglia and demyelination damage in white matter (2018) (0)

This paper list is powered by the following services:

Other Resources About Peter Calabresi

en.wikipedia.org

What Schools Are Affiliated With Peter Calabresi?

Peter Calabresi is affiliated with the following schools: